Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Total Current Liabilities (2022 - 2025)

Historic Total Current Liabilities for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $29.1 million.

  • Prokidney's Total Current Liabilities rose 1541.64% to $29.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.1 million, marking a year-over-year increase of 1541.64%. This contributed to the annual value of $36.2 million for FY2024, which is 4464.81% up from last year.
  • Per Prokidney's latest filing, its Total Current Liabilities stood at $29.1 million for Q3 2025, which was up 1541.64% from $28.3 million recorded in Q2 2025.
  • Prokidney's 5-year Total Current Liabilities high stood at $36.2 million for Q4 2024, and its period low was $5.4 million during Q1 2022.
  • Over the past 4 years, Prokidney's median Total Current Liabilities value was $21.0 million (recorded in 2023), while the average stood at $20.5 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 20877.05% in 2023, then plummeted by 1595.3% in 2024.
  • Quarter analysis of 4 years shows Prokidney's Total Current Liabilities stood at $10.9 million in 2022, then skyrocketed by 130.28% to $25.0 million in 2023, then surged by 44.65% to $36.2 million in 2024, then decreased by 19.75% to $29.1 million in 2025.
  • Its Total Current Liabilities stands at $29.1 million for Q3 2025, versus $28.3 million for Q2 2025 and $32.8 million for Q1 2025.